India is building more than 34,000 new private hospital beds over the next five years. More than a third of these will come up in Tier II and III cities, taking organized healthcare and its hygiene requirements deeper into the country. Every new hospital, every new bed, every new ICU, every new diagnostic center and every new medical college create recurring demand for cleaning equipment, chemicals, laundry systems, infection prevention products and washroom hygiene solutions. As healthcare expands beyond the metros, a significant new market is opening for the professional cleaning industry. Editor Mohana M examines the market opportunity emerging from this healthcare expansion.
In a thematic report released in February 2026, a rating agency projects that its sample set of 18 large private hospital chains will add more than 34,000 beds between FY2026 and FY2030 — a cumulative 48-50% increase over their own capacity as it stood on March 31, 2025, funded through internal accruals, equity raises, cash balances and incremental debt.
That is the single most useful figure for anyone selling cleaning equipment, chemicals or washroom hygiene into Indian healthcare. It is a five-year commissioning pipeline with dates attached. ICRA is careful about what it does not mean: Across India’s total private bed base, 34,000 beds is an addition of only 2.3-2.5%. The significance is concentration, not aggregate volume — these are the chains most likely to buy mechanised equipment and run documented protocols.
The geography is where the story sits. ICRA estimates more than 13,400 beds, or 38-40% of the planned additions, will come up in tier II and tier III cities, with the balance in metros. By region, North India takes 42-44%, the South 31-33% and the West 16-18%, with East and Central India accounting for the rest.
The public pipeline runs alongside it, though its scheme period has just closed. Prime Minister Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) was launched in October 2021 with an outlay of ₹64,180 crore across FY2021-22 to FY2025-26, of which ₹54,204.78 crore sits in the Centrally Sponsored Scheme component and ₹9,339.78 crore in the Central Sector component. Under the CSS component, administrative approval has been accorded to states and union territories for ₹32,928.82 crore covering 9,519 sub-health centre Ayushman Arogya Mandirs, 5,456 urban AAMs, 2,151 block public health units, 744 integrated public health labs at district level and 621 critical care blocks.
The sanctioned CCB target is 602 blocks, one in every district with a population above five lakhs, each of 50 to 100 beds with ICU capacity, independent oxygen plants and segregated infectious disease zones. A further 150-bed critical care hospital block has been approved at each of 12 central institutions, including AIIMS Bhopal, Bhubaneswar, Jodhpur, Patna, Rishikesh and Raipur.
Union Budget 2026-27 raised the PM-ABHIM allocation from ₹2,845 crore under FY26 revised estimates to ₹4,770 crore, a 67.66% jump, within a total health ministry allocation of ₹1,06,530.42 crore.
One caution for anyone to build a sales forecast on the public pipeline: Approval is not commissioning. PM-ABHIM has recorded utilisation as low as 29-43% of budget estimates in FY2022-23 and FY2023-24, improving to about 65% in FY2024-25. The blocks are coming, but the dates slip.
Where the demand is actually moving
IBEF’s 2026 healthcare update carries the clearest split available: healthcare demand in tier II and tier III cities is projected to grow at 16-18% CAGR, against 12-14% in the metros. Tier II cities are expected to add 40 million people by FY27.
The demand-supply logic behind that is not subtle. India has roughly 1.3 hospital beds per 1,000 population — about 13 per 10,000 — against a global median of 29 per 10,000. Around 65% of the population lives in tier II and tier III cities and rural areas, while tertiary and quaternary capacity remains concentrated in the metros. Public expenditure on health is expected to be 1.9% of GDP in FY26 against 2.5% in FY25, per the Economic Survey 2024-25. The private sector carries about 62-63% of hospitals and 59-60% of beds.
Insurance is what converted that gap into a bankable market. As on 28 February 2026, PM-JAY had generated 43.52 crore Ayushman cards, including 1.14 crore Ayushman Vay Vandana cards for citizens aged 70 and above, and had empaneled 36,229 hospitals — 19,483 public and 16,746 private. As on 30 June 2026, the scheme had authorised 12.69 crore hospital admissions and approved claims worth more than ₹1.92 lakh crore. IBEF reports that 70% of hospitals were empaneled under Ayushman Bharat as of 2025. A 100-bed hospital in a district town is now viable in a way it was not a decade ago.
The chains have responded. Apollo operated 8,131 beds as of March 2026 at 68% occupancy, with 4,400 capacity beds — roughly 3,600 census beds — to be commissioned over five years against a remaining capex pipeline near ₹5,100 crore, funded through internal accruals.
Manipal, which listed at a 10.5% premium after a ₹9,275 crore IPO subscribed 4.92 times, has committed around ₹4,000 crore to add roughly 2,400 beds within three to four years, an increase of over 18% on a base of 49 hospitals and 13,037 licensed beds across 14 states and union territories, 41 of them NABH-accredited.
Narayana Health is targeting 7,600-plus beds by FY30, Yatharth roughly 5,000 within three years, KIMS 1,800 beds across seven cities, Medanta about 2,700 beds on ₹4,500 crore of capex, and the combined Aster DM-Quality Care platform around 4,445 beds. Max is expanding into Lucknow, Pune, Dwarka and Dehradun. Jupiter is building out Maharashtra. Paras, which filed its prospectus in June 2026, is going into tier II and tier III North India.
EY’s mid-2026 read on the sector notes that these chains are leaning on brownfield expansion, O&M agreements and acquisitions to grow faster on less capital — which matters commercially, because brownfield and O&M sites arrive with existing housekeeping contracts to displace rather than greenfield contracts to win.
Why beds convert to cleaning spend
The installed base is larger than most equipment suppliers assume. CPCB’s biomedical waste annual report for 2023 counts 4,35,257 healthcare facilities in India, of which 1,37,132 are bedded, carrying 30,91,847 beds between them, with a further 2,98,125 non-bedded facilities. Those facilities generated about 743 tonnes of biomedical waste a day, of which 694 tonnes was treated and disposed of through common and captive treatment facilities.
Roughly 30.9 lakh beds is the addressable base today. The five-year build-out adds to it at both ends — corporate chains at the top, district critical care blocks and 50-100 bed nursing homes underneath.
The clinical case for spending on cleaning is stronger in India than almost anywhere. WHO estimates that HAIs affect 7-15% of hospitalised patients depending on income setting; published Indian estimates put the domestic burden at 10-20%. The Healthcare-Associated Infection Surveillance Network, run since 2017 by AIIMS New Delhi with technical support from ICMR, has published seven-year data from 180 ICUs across 47 tertiary care hospitals covering May 2017 to April 2024.
Carbapenem resistance in that dataset reached 87.1% of Acinetobacter baumannii isolates tested and 77.7% of Klebsiella pneumoniae — well above the 53-77% range the network reported in its earlier 26-hospital work. Environmental cleaning and hand hygiene are the cheapest interventions in that fight, and the only ones a housekeeping supplier can sell.
Accreditation Advantage
The bigger shift is the deadline. From 1 October 2026, hospitals above 300 beds will no longer be able to obtain HOPE entry-level certification and are expected to move to full NABH hospital accreditation. The cliff has a slope to it: such hospitals may apply for entry-level certification until 30 September 2026 on an exceptional basis, at ₹2 lakh for 301-500 beds, and that certificate remains valid for two years.
The practical effect is a defined cohort of mid-size hospitals — many of them in tier II cities — moving up a compliance tier between now and 2028. Full accreditation raises documentation, validation and consumable requirements in exactly the areas CIJ readers supply.
The commercial trigger in tier II and III is not clinical conviction. It is accreditation economics.
Under PM-JAY operational guidelines, hospitals holding a valid NABH entry-level certification are reimbursed at a 10% uplift on the base package rate for every claim, for the full two-year validity of the certificate. Certification fees, revised with effect from June 2025, run from ₹21,000 for facilities up to five beds to ₹96,000 for 51-100 beds and ₹1,20,000 for 101-300 beds, before GST.
For a 50-bed hospital running PM-JAY volumes, the incentive pays back certification cost well inside the validity period. NABH’s hospital infection control chapter covers hand hygiene, environmental cleaning and biomedical waste — meaning cleaning protocol, product dossiers and staff training documentation are audit line items, not discretionary spend.
The bigger shift is a deadline. From October 1, 2026, hospitals above 300 beds will no longer be able to obtain HOPE entry-level certification and are expected to move to full NABH hospital accreditation. The cliff has a slope to it: such hospitals may apply for entry-level certification until 30 September 2026 on an exceptional basis, at ₹2 lakh for 301-500 beds, and that certificate remains valid for two years.
The practical effect is a defined cohort of mid-size hospitals — many of them in tier II cities — moving up a compliance tier between now and 2028.
The five-year market numbers
Facility management is where the healthcare growth shows up most clearly. Mordor Intelligence sizes India’s FM market at ₹7.67 lakh crore in 2025, rising to ₹8.28 lakh crore in 2026 and ₹11.78 lakh crore by 2031 at 7.29% CAGR. Within it, healthcare is the fastest-growing vertical at 9.42% CAGR to 2031 — ahead of industrial, which is the largest at 34.42% of 2025 revenue. Soft services accounted for 66.52% of 2025 revenue; outsourced integrated contracts, at 9.03% annual growth, are set to reach nearly a third of the market by 2031.
A caution worth mentioning. Mordor’s own benchmarking table shows other publishers sizing the same India FM market at ₹27,170 crore and ₹29,830 crore for 2025, because they count only organised outsourced soft services and exclude in-house delivery and much of hard services. The gap is definitional, not arithmetical. Any figure quoted for this market needs its scope stated alongside it. (Figure below)
Grand View rates India the fastest-growing contract cleaning market in the world by country CAGR, on a 2023 base that represented 5.4% of global revenue.
Within chemicals, the healthcare-specific line is the sharpest. Globally, Mordor has disinfectants and sanitisers growing faster than general-purpose cleaners at 6.7% CAGR, driven by sustained healthcare and foodservice protocols, with Asia Pacific the fastest region at 7.8%. Mordor’s global surface disinfectant work notes that new tertiary hospitals opening across India are designing in infection-control alcoves, automated dilution centres and segregated storage bays — a shift that pushes procurement towards bulk concentrates with closed-loop dispensing, raising contract values while cutting packaging.
On washroom hygiene, the healthcare read-across is direct: Mordor finds hospitals and healthcare facilities the fastest-growing end-user segment at 8.52% CAGR to 2031, against 28.87% of 2025 revenue held by commercial offices, with Asia Pacific expanding at 8.07%. Wipes are the fastest-growing product category at 8.41% CAGR, ahead of paper towels which held 32.10% of 2025 revenue — healthcare’s preference for pre-moistened disinfectant wipes is a large part of why. For India specifically, MarkNtel projects AFH tissue and hygiene at around 6.8% CAGR.
India-specific professional cleaning equipment data is the weakest link in the chain; most published India numbers for this segment are either unreliable or unpublished. The defensible reads are directional. Asia-Pacific held 17.4% of the global floor cleaning equipment market in 2023 and is growing fastest; for industrial and commercial floor scrubbers specifically, the region is projected at 11.5% CAGR to 2030.
Taken together: a defensible editorial line is that healthcare-linked cleaning demand in India grows in the high single digits to low double digits annually to 2030-31, faster than the cleaning market as a whole in every segment where healthcare is broken out separately.
What changes when the buyer is in Jabalpur
Four things, and each one is a commercial problem for suppliers.
There is no legacy housekeeping department to displace. Mordor finds that secondary cities such as Kochi, Ahmedabad and Jaipur outsource from day one because they have no in-house teams, and that tier II penetration of integrated FM is running ahead of metro levels. Outcome-based contracts already make up about a third of awards in these cities, against roughly a quarter of new awards nationally. Quess booked ₹250 crore of multi-year tier II integrated FM contracts across Ahmedabad, Jaipur and Kochi in January 2026. Bundled two-or-three-service deals are the standard entry format.
Procurement is price-led and fragmented. Lowest-price tendering dominates in the public sector and among smaller private hospitals. Each building issues its own bid, which prevents scale benefits in consumables and staffing. Nationally, in-house delivery still accounted for 67.56% of FM revenue in 2025.
Input costs are rising faster than contract values. Cleaning chemicals rose 6-10% in 2025, diesel for backup generators 8% and insurance premiums up to 15%, while public-sector and SME clients held rates flat. Wage inflation of 10-12% compresses margins where contracts lack escalation clauses.
Labour is the binding constraint. Housekeeping and guarding attrition exceeded 40% in metros in 2025 as workers moved to e-commerce and gig platforms. Vocational institutes graduate fewer than 50,000 HVAC and BMS technicians a year against demand near 150,000. In tier II and III cities the trained-operator pool for mechanised equipment is thinner still — which is the real reason scrubber-dryers lose tenders to mops in district hospitals, and the reason service network depth beats specification in these markets.
Biomedical waste compliance carries the same unevenness. CPCB’s own reporting shows facilities still using captive treatment including deep burial, and treatment infrastructure concentrated in urban areas. CPCB issued revised guidelines for common biomedical waste treatment and disposal facilities in April 2025, noting 234 CBWTFs in operation and 30 under construction as of 2023, and setting generation rates of 277 grams per bed per day for bedded facilities.
The read for suppliers
The five-year opportunity is not a metro opportunity with tier II upside attached. It is a distribution-and-service problem disguised as a market-size story.
The volume is real and dated — 34,000 private beds by FY2030, more than 13,400 of them outside the metros, 602 sanctioned district critical care blocks, a 300-bed accreditation transition beginning 1 October 2026. The buying triggers are documented and non-discretionary: NABH hospital infection control requirements, PM-JAY incentive economics, biomedical waste authorisation. The demand growth rate in healthcare beats every other end-use segment in Indian FM.
What is missing in tier II and III is not demand. It is trained operators, spares within a day’s reach, dosing systems that survive unsupervised use, chemical SKUs priced for a ₹15,000 PM-JAY package rather than the ₹71,206 a day Apollo booked per occupied bed in the March 2026 quarter, and a service engineer who answers the phone. Whoever solves that in the next 24 months will own the installed base for the decade after.
The Part II of this research will highlight the complete breakdown of these opportunities for the cleaning industry, including products, facility management, other services.
| Segment | Publisher | Base | Forecast | CAGR |
| India facility management | Mordor Intelli-gence | ₹7.67 lakh crore (2025) | ₹11.78 lakh crore (2031) | 7.29% |
| India contract cleaning services | Grand View Horizon | ₹1.85 lakh crore (2023) | ₹3.32 lakh crore (2030) | 8.7% |
| India cleaning services | TechSci | ₹85,690 crore (2024) | ₹1.33 lakh crore (2030) | 7.54% |
| India cleaning services | IMARC | ₹1.29 lakh crore (2024) | ₹2.31 lakh crore (2033) | 6.72% |
| India I&I cleaning chemi-cals | TechSci | ₹19,380 crore (2024) | ₹25,365 crore (2030) | 4.56% |
| India I&I cleaning chemi-cals | Grand View | — | ₹43,130 crore (2033) | 8.9% |
| India surface disinfectant | Grand View Horizon | ₹2,275 crore (2023) | ₹3,921 crore (2030) | 8.1% |
| Away-from-home tissue and hygiene (global) | Mordor Intelli-gence | ₹4.03 lakh crore (2025) | ₹5.57 lakh crore (2030) | 6.66% |
| Floor cleaning equipment (global) | Grand View | ₹1.22 lakh crore (2023) | ₹2.15 lakh crore (2030) | 8.5% |
| India commercial cleaning products | — | ₹25,650 crore (2023) | ₹36,195 crore (2029) | 6% |
| India healthcare clean-room technology | — | ₹1,384 crore (2023) | ₹2,258 crore (2030) | 7.2% |